Bisphosphonates are inhibitors of bone resorption that are widely used to treat osteoporosis. Price and colleagues demonstrate that ibandronate suppressed the development of uremia-related vascular calcification in rats. These findings extend the link between bone remodeling and vascular calcification to the context of chronic renal failure, opening perspectives toward novel therapeutic strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/sj.ki.5001899 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!